| SpectraBase Spectrum ID |
JIxs68wUUYS |
| Name |
1,4-Di-(4-Chlorobenzyl)-2-methylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
348.116004116 u |
| Formula |
C19H22Cl2N2 |
| InChI |
InChI=1S/C19H22Cl2N2/c1-15-12-22(13-16-2-6-18(20)7-3-16)10-11-23(15)14-17-4-8-19(21)9-5-17/h2-9,15H,10-14H2,1H3 |
| InChIKey |
YXSRUDNDQOIDBE-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
349.305 g/mol |
| Nominal Mass |
348 u |
| Quality |
992 |
| Retention Index |
2671 |
| SMILES |
C1(N(CCN(C1)CC=1C=CC(=CC1)Cl)CC=1C=CC(=CC1)Cl)C |
| SPLASH |
splash10-004i-2910000000-3e02c8d4b9dc1a2ef6c7 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1,4-di-(4-Chlorobenzyl)-2-methyl
1,4-bis(4-chlorobenzyl)-2-methylpiperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011212 |
